内科理论与实践 ›› 2023, Vol. 18 ›› Issue (02): 111-116.doi: 10.16138/j.1673-6087.2023.02.010
收稿日期:
2022-05-24
出版日期:
2023-04-25
发布日期:
2023-05-15
通讯作者:
陈锐 E-mail: 基金资助:
SHEN Honghua1, XU Yiming1, ZHANG Yin1, et al
Received:
2022-05-24
Online:
2023-04-25
Published:
2023-05-15
中图分类号:
沈宏华, 许轶明, 张音, 任蕾, 陈锐. 慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠综合征的研究进展[J]. 内科理论与实践, 2023, 18(02): 111-116.
SHEN Honghua, XU Yiming, ZHANG Yin, et al . Research progress on the overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnoea[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 111-116.
[1] |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
doi: 10.1016/S0140-6736(18)30841-9 URL |
[2] |
Arnardottir ES, Bjornsdottir E, Olafsdottir KA, et al. Obstructive sleep apnoea in the general population: highly prevalent but minimal symptoms[J]. Eur Respir J, 2016, 47(1): 194-202.
doi: 10.1183/13993003.01148-2015 pmid: 26541533 |
[3] |
Flenley DC. Sleep in chronic obstructive lung disease[J]. Clin Chest Med, 1985, 6(4): 651-661.
pmid: 2935359 |
[4] |
Shawon MS, Perret JL, Senaratna CV, et al. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease[J]. Sleep Med Rev, 2017, 32: 58-68.
doi: 10.1016/j.smrv.2016.02.007 URL |
[5] |
Soler X, Gaio E, Powell FL, et al. High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease[J]. Ann Am Thorac Soc, 2015, 12(8): 1219-1225.
doi: 10.1513/AnnalsATS.201407-336OC pmid: 25871443 |
[6] |
Naranjo M, Willes L, Prillaman BA, et al. Undiagnosed OSA may significantly affect outcomes in adults admitted for COPD in an inner-city hospital[J]. Chest, 2020, 158(3): 1198-1207.
doi: S0012-3692(20)30568-7 pmid: 32247716 |
[7] |
Silva JLR Júnior, Conde MB, Corrêa KS, et al. Sleep-disordered breathing in patients with COPD and mild hypoxemia: prevalence and predictive variables[J]. J Bras Pneumol, 2017, 43(3): 176-182.
doi: S1806-37132017000300176 pmid: 28746527 |
[8] | 沈久成, 孙丽, 王婧, 等. 阻塞性睡眠呼吸暂停对慢性阻塞性肺疾病患者心肺功能的影响[J]. 中华医学杂志, 2021, 101(22): 1665-1670. |
[9] |
McNicholas WT. Impact of sleep in COPD[J]. Chest, 2000, 117(2 Suppl): 48S-53S.
doi: 10.1378/chest.117.2_suppl.48s pmid: 10673475 |
[10] |
Tuleta I, Stöckigt F, Juergens UR, et al. Intermittent hypoxia contributes to the lung damage by increased oxidative stress, inflammation, and disbalance in protease/antiprotease system[J]. Lung, 2016, 194: 1015-1020.
pmid: 27738828 |
[11] |
Dewan NA, Nieto FJ, Somers VK. Intermittent hypoxemia and OSA: implications for comorbidities[J]. Chest, 2015, 147(1): 266-274.
doi: S0012-3692(15)30258-0 pmid: 25560865 |
[12] | Zhang XL, Gao B, Han T, et al. Moderate-to-severe obstructive sleep apnea and cognitive function impairment in patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2020, 27(15): 1813-1822. |
[13] | Rodrigues F, Papoila AL, Ligeiro D, et al. Acute exercise amplifies inflammation in obese patients with COPD[J]. Rev Port Pneumol (2016), 2006, 22(6): 315-322. |
[14] | Wan N, Tang X, Ding H, et al. Influence of coexistence of mild OSA on airway mucus hypersecretion in patients with COPD[EB/J]. J Breath Res, 2021.https://doi.org/10.1088/1752-7163/abd52e. |
[15] |
Wang Y, Hu K, Liu K, et al. Obstructive sleep apnea exacerbates airway inflammation in patients with chronic obstructive pulmonary disease[J]. Sleep Med, 2015, 16(9): 1123-1130.
doi: 10.1016/j.sleep.2015.04.019 pmid: 26298789 |
[16] |
Macrea M, Campbell S, Martin T, et al. The peripheral neutrophils in subjects with COPD-OSA overlap syndrome and severe comorbidities: a feasible inflammatory biomarker?[J]. Adv Clin Exp Med, 2018, 27(12): 1677-1682.
doi: 10.17219/acem/75904 pmid: 30085419 |
[17] |
Krishnan V, Dixon-Williams S, Thornton JD. Where there is smoke—there is sleep apnea: exploring the relationship between smoking and sleep apnea[J]. Chest, 2014, 146(6): 1673-1680.
doi: S0012-3692(15)51539-0 pmid: 25451354 |
[18] |
Yang X, Tang X, Cao Y, et al. The bronchiectasis in COPD-OSA overlap syndrome patients[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15: 605-611.
doi: 10.2147/COPD.S243429 URL |
[19] |
McNicholas WT. COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management[J]. Chest, 2017, 152(6): 1318-1326.
doi: S0012-3692(17)30742-0 pmid: 28442310 |
[20] |
Poulain M, Doucet M, Major GC, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies[J]. CMAJ, 2006, 174(9): 1293-1299.
pmid: 16636330 |
[21] |
Messineo L, Lonni S, Magri R, et al. Lung air trapping lowers respiratory arousal threshold and contributes to sleep apnea pathogenesis in COPD patients with overlap syndrome[J]. Respir Physiol Neurobiol, 2020, 271: 103315.
doi: 10.1016/j.resp.2019.103315 URL |
[22] |
Lee CH, Sethi R, Li R, et al. Obstructive sleep apnea and cardiovascular events after pereutaneous coronary intervention[J]. Circulation, 2016, 133(21): 2008-2017.
doi: 10.1161/CIRCULATIONAHA.115.019392 URL |
[23] | Papachatzakis I, Velentza L, Zarogoulidis P, et al. Comorbidities in coexisting chronic obstructive pulmonary di-sease and obstructive sleep apnea-overlap syndrome[J]. EurRev Med Pharmacol Sci, 2018, 22(13): 4325-4331. |
[24] | 阻塞性睡眠呼吸暂停与卒中诊治专家共识写作组. 阻塞性睡眠呼吸暂停与卒中诊治专家共识[J]. 中华内科杂志, 2014, 53(8): 657-664. |
[25] |
Khurana S, Ravi A, Sutula J, et al. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers[J]. Respir Med, 2014, 108(12): 1761-1770.
doi: 10.1016/j.rmed.2014.09.020 pmid: 25459449 |
[26] |
Unnikrishnan D, Jun J, Polotsky V. Inflammation in sleep apnea: an update[J]. Rev Endocr Metab Disord, 2015, 16(1): 25-34.
doi: 10.1007/s11154-014-9304-x URL |
[27] |
Adir Y, Humbert M, Chaouat A. Sleep-related breathing disorders and pulmonary hypertension[J]. Eur Respir J, 2021, 57(1): 2002258.
doi: 10.1183/13993003.02258-2020 URL |
[28] |
Adler D, Bailly S, Benmerad M, et al. Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome[J]. PLoS One, 2020, 15(7): e0235331.
doi: 10.1371/journal.pone.0235331 URL |
[29] |
Fitzgibbons CM, Goldstein RL, Gottlieb DJ, et al. Physical activity in overlap syndrome of COPD and obstructive sleep apnea: relationship with markers of systemic inflammation[J]. J Clin Sleep Med, 2019, 15(7): 973-978.
doi: 10.5664/jcsm.7874 pmid: 31383234 |
[30] |
Vitacca M, Paneroni M, Braghiroli A, et al. Exercise capacity and comorbidities in patients with obstructive sleep apnea[J]. J Clin Sleep Med, 2020, 16(4): 531-538.
doi: 10.5664/jcsm.8258 pmid: 32003743 |
[31] |
Trimer R, Zangrando KL, et al. Overlap syndrome: the coexistence of OSA further impairs cardio respiratory fitness in COPD[J]. Sleep Breath, 2020, 24(4): 1451-1462.
doi: 10.1007/s11325-019-02002-2 |
[32] | Kennedy K, Corby C, Noctor E. Manic-like presentation with an organic aetiology[J]. Ir J Psychol Med, 2020, 7: 1-4. |
[33] |
Economou NT, Ilias I, Velentza L, et al. Sleepiness, fatigue, anxiety and depression in chronic obstructive pulmonary disease and obstructive sleep apnea-overlap-syndrome, before and after continuous positive airways pressure therapy[J]. PLoS One, 2018, 13(6):e0197342.
doi: 10.1371/journal.pone.0197342 URL |
[34] |
Olaithe M, Bucks RS, Hillman DR, et al. Cognitive deficits in obstructive sleep apnea: insights from a meta-review and comparison with deficits observed in COPD, insomnia, and sleep deprivation[J]. Sleep Med Rev, 2018, 38: 39-49.
doi: S1087-0792(17)30070-9 pmid: 28760549 |
[35] | Singh S, Kaur H, Singh S, et al. The overlap syndrome[J]. Cureus, 2018, 10(10): e3453. |
[36] |
Ustun B, Westover MB, Rudin C, et al. Clinical prediction models for sleep apnea: the importance of medical history over symptoms[J]. J Clin Sleep Med, 2016, 12(2):161-168.
doi: 10.5664/jcsm.5476 pmid: 26350602 |
[37] |
Soler X, Liao SY, Marin JM, et al. Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease(COPD)[J]. PLoS One, 2017, 12(5): e0177289.
doi: 10.1371/journal.pone.0177289 URL |
[38] |
Nagappa M, Liao P, Wong J, et al. Validation of the STOP-bang questionnaire as a screening tool for obstructive sleep apnea among different populations[J]. PLoS One, 2015, 10(12): e0143697.
doi: 10.1371/journal.pone.0143697 URL |
[39] |
Marti-Soler H, Hirotsu C, Marques-Vidal P, et al. The NoSAS score for screening of sleep disordered breathing: a derivation and validation study[J]. Lancet Respir Med, 2016, 4(9): 742-748.
doi: 10.1016/S2213-2600(16)30075-3 pmid: 27321086 |
[40] | 陈安书, 汪柯馨, 应珂璐, 等. 关于美国胸科协会对慢性阻塞性肺疾病合并睡眠呼吸障碍的病理生理学主要问题的官方声明的解读[J]. 世界临床药物, 2022, 43(3):226-232. |
[41] |
Singh S, Khan SZ, Singh D, et al. The uses of overnight pulse oximetry[J]. Lung India, 2020, 37(2): 151-157.
doi: 10.4103/lungindia.lungindia_302_19 pmid: 32108601 |
[42] | Braghiroli A, Sacco C, Erbetta M, et al. Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure[J]. Am Rev Respir Dis, 1993, 48(1): 173-178. |
[43] |
Dragonieri S, Quaranta VN, Carratu P, et al. Exhaled breath profiling in patients with COPD and OSA overlap syndrome[J]. J Breath Res, 2016, 10(4): 041001.
doi: 10.1088/1752-7155/10/4/041001 URL |
[44] |
Dumitrache-Rujinski S, Călcăianu G, Bogdan M. Devices used in non-invasive ventilation for obstructive sleep apnea associating COPD and/or morbid obesity[J]. Pneumologia, 2013, 62(2): 106-109.
pmid: 23894792 |
[45] | Stanchina ML, Welicky LM, Donat W, et al. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome[J]. J Clin Sleep, 2013, 9(8): 767-772. |
[46] |
Singh G, Agarwal A, Zhang W, et al. Impact of PAP therapy on hospitalization rates in medicare beneficiaries with COPD and coexisting OSA[J]. Sleep Breath, 2019, 23(1): 193-200.
doi: 10.1007/s11325-018-1680-0 pmid: 29931497 |
[47] |
Lacedonia D, Carpagnano GE, Aliani M, et al. Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome)[J]. Respir Med, 2013, 107(2): 310-316.
doi: 10.1016/j.rmed.2012.10.012 pmid: 23141861 |
[48] |
Toraldo DM, De Nuccio F, Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study[J]. Sleep Breath, 2010, 14(2): 115-123.
doi: 10.1007/s11325-009-0291-1 pmid: 19756803 |
[49] |
Kuklisova Z, Tkacova R, Joppa P, et al. Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome[J]. Sleep Med, 2017, 30(1): 139-145.
doi: 10.1016/j.sleep.2016.02.012 URL |
[50] |
Carlucci A, Ceriana P, Mancini M, et al. Efficacy of bilevel-auto treatment in patients with obstructive sleep apnea not responsive to or intolerant of continuous positive airway pressure ventilation[J]. J Clin Sleep Med, 2015, 11(9): 981-985.
doi: 10.5664/jcsm.5008 pmid: 25902825 |
[51] |
Kuklisova Z, Tkacova R, Joppa P, et al. Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome[J]. Sleep Med, 2017, 30: 139-145.
doi: S1389-9457(16)30007-7 pmid: 28215237 |
[52] |
Su M, Huai D, Cao J, et al. Auto-trilevel versus bilevel positive airway pressure ventilation for hypercapnic overlap syndrome patients[J]. Sleep Breath, 2018, 22(1): 65-70.
doi: 10.1007/s11325-017-1529-y URL |
[53] |
Ioachimescu OC, Janocko NJ, Ciavatta MM, et al. Obstructive lung disease and obstructive sleep apnea (OLDOSA) cohort study[J]. J Clin Sleep Med, 2020, 16(2):267-277.
doi: 10.5664/jcsm.8180 pmid: 31992433 |
[54] |
Dumitrache-Rujinski S, Croitoru A, Bogdan MA. Therapeutical approach in severe exacerbation of COPD associating obstructive sleep apnoea and obesity[J]. Pneumologia, 2012, 61(2): 117-119.
pmid: 22783604 |
[55] | Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary[J]. Arch Bronconeumol, 2017, 53(3): 118-149. |
[56] |
Paneroni M, Colombo F, Papalia A, et al. Is telerehabilitation a safe and viable option for patients with COPD?[J]. COPD, 2015, 12(2): 217-225.
doi: 10.3109/15412555.2014.933794 pmid: 25093419 |
[57] |
Sengul YS, Ozalevli S, Oztura I, et al. The effect of exercise on obstructive sleep apnea: a randomized and controlled trial[J]. Sleep Breath, 2011, 15(1): 49-56.
doi: 10.1007/s11325-009-0311-1 pmid: 19898884 |
[58] | 杜井波, 沈宏华, 许轶明, 等. 慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠综合征特点分析及康复疗效[J]. 内科理论与实践, 2020, 15(1): 31-37. |
[59] |
Limsuwat C, McClellan R, Amiri HM, et al. Pulmonary rehabilitation improves only some domains of health-related quality of life measured by the short form-36 questionnaire[J]. Ann Thorac Med, 2014, 9(3): 144-148.
doi: 10.4103/1817-1737.134068 pmid: 24987472 |
[60] |
Loredo JS, Ancoli-Israel S, Kim EJ, et al. Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea[J]. Sleep, 2006, 29(4): 564-571.
doi: 10.1093/sleep/29.4.564 pmid: 16676791 |
[61] |
Biselli PJ, Kirkness JP, Grote L, et al. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study[J]. J Appl Physiol (1985), 2017, 122(1): 82-88.
doi: 10.1152/japplphysiol.00279.2016 URL |
[62] |
McNicholas WT, Coffey M, Boyle T. Effects of nasal airflow on breathing during sleep in normal humans[J]. Am Rev Respir Dis, 1993, 147(3): 620-623.
doi: 10.1164/ajrccm/147.3.620 URL |
[63] |
McGinley BM, Patil SP, Kirkness JP, et al. A nasal cannula can be used to treat obstructive sleep apnea[J]. Am J Respir Crit Care Med, 2007, 176(2): 194-200.
doi: 10.1164/rccm.200609-1336OC URL |
[64] |
Sarber KM, Chang KW, Epperson MV, et al. Hypoglossal nerve stimulation in veterans with obstructive sleep apnea[J]. Laryngoscope, 2020, 130(9): 2275-2280.
doi: 10.1002/lary.28422 |
[65] |
Poulain M, Doucet M, Major GC, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies[J]. CMAJ, 2006, 174(9): 1293-1299.
pmid: 16636330 |
[66] |
Vanfleteren LE, Beghe B, Andersson A, et al. Multimorbidity in COPD, does sleep matter?[J]. Eur J Intern Med, 2020, 73: 7-15.
doi: S0953-6205(19)30470-4 pmid: 31980328 |
[1] | 何鑫, 莫华恒, 胡克. 上气道电刺激治疗阻塞性睡眠呼吸暂停的研究现状[J]. 内科理论与实践, 2023, 18(02): 117-120. |
[2] | 张璐璐, 武倩男, 霍如婕, 田新瑞. 微RNA-206与肺部疾病的研究进展[J]. 内科理论与实践, 2022, 17(05): 413-417. |
[3] | 周思锋, 徐海舒, 范欣生. 基于不同生物样本代谢组学的OSAHS生物标志物研究进展[J]. 诊断学理论与实践, 2022, 21(04): 535-540. |
[4] | 孙娴雯, 李庆云. 新型冠状病毒疫情时期的慢性阻塞性肺疾病管理策略——2022版慢性阻塞性肺疾病全球倡议解读[J]. 诊断学理论与实践, 2022, 21(01): 32-37. |
[5] | 仇丽雯, 许轶明, 张音, 沈宏华, 陈慎. 抗阻联合有氧训练对老年慢性阻塞性肺疾病患者运动能力的疗效[J]. 内科理论与实践, 2022, 17(01): 78-83. |
[6] | 刘礼银, 胡系伟, 杨然. 远程医疗在慢性阻塞性肺疾病患者肺康复中的应用价值[J]. 内科理论与实践, 2022, 17(01): 97-101. |
[7] | 陆春华, 王凯, 曾贞, 张琴, 何雯, 郑春红, 张晓, 李果. 三维打印分指板对脑卒中早期患者手指痉挛的疗效评价[J]. 内科理论与实践, 2021, 16(04): 255-260. |
[8] | 许轶明, 沈宏华, 张音, 任蕾. 阻塞性睡眠呼吸暂停与卒中[J]. 内科理论与实践, 2021, 16(04): 276-281. |
[9] | 胡克, 杨海珍, 岳芳. 新型冠状病毒肺炎疫情对阻塞性睡眠呼吸暂停诊治的影响及对策[J]. 内科理论与实践, 2021, 16(02): 73-75. |
[10] | 王利娟, 王蓓. 阻塞性睡眠呼吸暂停与眼部疾病研究进展[J]. 内科理论与实践, 2021, 16(02): 134-137. |
[11] | 李庆云, 李诗琪, 周剑平. 阻塞性睡眠呼吸暂停与吸烟的交互影响[J]. 内科理论与实践, 2021, 16(02): 76-79. |
[12] | 王建丽, 张立强. 睡眠呼吸障碍与肺动脉高压[J]. 内科理论与实践, 2021, 16(02): 80-83. |
[13] | 李玉柱, 高秉睿. 阻塞性睡眠呼吸暂停和慢性阻塞性肺疾病重叠综合征的新认识[J]. 内科理论与实践, 2021, 16(02): 88-92. |
[14] | 崔小川, 张希龙. 阻塞性睡眠呼吸暂停低通气综合征与支气管哮喘[J]. 内科理论与实践, 2021, 16(02): 93-96. |
[15] | 许磊, 许轶明, 沈宏华, 张音, 任蕾. 阻塞性睡眠呼吸暂停合并卒中对睡眠及神经认知功能的影响[J]. 内科理论与实践, 2021, 16(02): 97-102. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||